Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug;41(4):251-262.
doi: 10.4093/dmj.2017.41.4.251.

The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis

Affiliations
Review

The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis

Jinyue Yu et al. Diabetes Metab J. 2017 Aug.

Abstract

Green tea or green tea extract (GT/GTE) has been demonstrated to reduce insulin resistance and improve glycemic control. However, evidence for this health beneficial effect is inconsistent. This systematic review evaluated the effect of GT/GTE on insulin resistance and glycemic control in people with pre-diabetes/type 2 diabetes mellitus (T2DM). Ovid MEDLINE, Embase, AMED, Web of Science, and the Cochrane Library were searched up to April 2017 for randomised controlled trials of participants with pre-diabetes or T2DM, where the intervention was GT/GTE. Meta-analysis was performed to assess the standardised mean difference (SMD) in biomarkers of insulin resistance and glycemic control between GT/GTE and placebo groups. Six studies (n=382) were pooled into random-effects meta-analysis. Overall, no differences were found between GT/GTE and the placebo for glycosylated hemoglobin (HbA1c: SMD, -0.32; 95% confidence interval [CI], -0.86 to 0.23), homeostatic model assessment for insulin resistance (HOMA-IR: SMD, 0.10; 95% CI, -0.17 to 0.38), fasting insulin (SMD, -0.25; 95% CI, -0.64 to 0.15), and fasting glucose (SMD, -0.10; 95% CI, -0.50 to 0.30). No evidence support the consumption of GT/GTE could reduce the levels of HbA1c, HOMA-IR, fasting insulin, or fasting glucose in people with pre-diabetes/T2DM. However, the studies included were small and of varying quality.

Keywords: Diabetes mellitus, type 2; Glycemic control; Green tea; Insulin resistance; Meta-analysis.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1. Flow-chart of study selection and exclusion in details.
Adapted from www.mdpi.com/link.
Fig. 2
Fig. 2. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Fig. 3
Fig. 3. Meta-analysis results for each assessed outcome. (A) Comparison between decaffeinated green tea extract and placebo, outcome: glycosylated hemoglobin (HbA1c, %). (B) Comparison between decaffeinated green tea extract and green tea extract, outcome: fasting glucose. (C) Comparison between decaffeinated green tea extract and green tea extract, outcome: fasting insulin. (D) Comparison between decaffeinated green tea extract and green tea extract versus placebo, outcome: homeostatic model assessment for insulin resistance (HOMA-IR). SD, standard deviation; IV, independent variable; CI, confidence interval.

References

    1. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000. - PubMed
    1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–846. - PubMed
    1. World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014. - PubMed
    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–S69. - PMC - PubMed
    1. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53:1270–1287. - PMC - PubMed

LinkOut - more resources